FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1326110 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
Zu cristatus Preferred (foundation metadata concept)
Zu cristatus (organism) Preferred (foundation metadata concept)
Zucchini Preferred (foundation metadata concept)
Zucchini (substance) Preferred (foundation metadata concept)
Zucchini and potato curry Preferred (foundation metadata concept)
Zucchini and potato curry (substance) Preferred (foundation metadata concept)
Zucchini with egg Preferred (foundation metadata concept)
Zucchini with egg (substance) Preferred (foundation metadata concept)
Zuclopenthixol Preferred (foundation metadata concept)
Zuclopenthixol Acceptable (foundation metadata concept)
Zuclopenthixol (as zuclopenthixol dihydrochloride) 10 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol (as zuclopenthixol dihydrochloride) 2 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol (as zuclopenthixol dihydrochloride) 25 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol (substance) Preferred (foundation metadata concept)
Zuclopenthixol 10 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol 2 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol 25 mg oral tablet Preferred (foundation metadata concept)
Zuclopenthixol acetate Preferred (foundation metadata concept)
Zuclopenthixol acetate Preferred (foundation metadata concept)
Zuclopenthixol acetate (substance) Preferred (foundation metadata concept)
Zuclopenthixol acetate 100 mg/2 mL solution for injection ampoule Acceptable (foundation metadata concept)
Zuclopenthixol acetate 100 mg/2 mL solution for injection ampule Preferred (foundation metadata concept)
Zuclopenthixol acetate 100mg/2mL oily injection Acceptable (foundation metadata concept)
Zuclopenthixol acetate 50 mg/mL solution for injection Preferred (foundation metadata concept)
Zuclopenthixol acetate 50 mg/mL solution for injection ampoule Acceptable (foundation metadata concept)
Zuclopenthixol acetate 50 mg/mL solution for injection ampule Preferred (foundation metadata concept)
Zuclopenthixol acetate 50mg/1mL oily injection Acceptable (foundation metadata concept)
Zuclopenthixol acetate 50mg/mL injection solution 1mL ampule Preferred (foundation metadata concept)
Zuclopenthixol acetate 50mg/mL injection solution 1mL ampule (product) Preferred (foundation metadata concept)
Zuclopenthixol acetate 50mg/mL injection solution 2mL ampule Preferred (foundation metadata concept)
Zuclopenthixol acetate 50mg/mL injection solution 2mL ampule (product) Preferred (foundation metadata concept)
Zuclopenthixol adverse reaction Preferred (foundation metadata concept)
Zuclopenthixol adverse reaction (disorder) Preferred (foundation metadata concept)
Zuclopenthixol allergy Acceptable (foundation metadata concept)
Zuclopenthixol decanoate Preferred (foundation metadata concept)
Zuclopenthixol decanoate (substance) Preferred (foundation metadata concept)
Zuclopenthixol decanoate 200 mg/mL solution for injection Preferred (foundation metadata concept)
Zuclopenthixol decanoate 200 mg/mL solution for injection ampoule Acceptable (foundation metadata concept)
Zuclopenthixol decanoate 200 mg/mL solution for injection ampule Preferred (foundation metadata concept)
Zuclopenthixol decanoate 200mg/1mL oily injection Acceptable (foundation metadata concept)
Zuclopenthixol decanoate 200mg/mL injection solution 1mL ampule Preferred (foundation metadata concept)
Zuclopenthixol decanoate 200mg/mL injection solution 1mL ampule (product) Preferred (foundation metadata concept)
Zuclopenthixol decanoate 500 mg/mL solution for injection Preferred (foundation metadata concept)
Zuclopenthixol decanoate 500 mg/mL solution for injection ampoule Acceptable (foundation metadata concept)
Zuclopenthixol decanoate 500 mg/mL solution for injection ampule Preferred (foundation metadata concept)
Zuclopenthixol decanoate 500mg/1mL oily injection Acceptable (foundation metadata concept)
Zuclopenthixol decanoate 500mg/mL injection solution 1mL ampule Preferred (foundation metadata concept)
Zuclopenthixol decanoate 500mg/mL injection solution 1mL ampule (product) Preferred (foundation metadata concept)
Zuclopenthixol decanoate adverse reaction Preferred (foundation metadata concept)
Zuclopenthixol decanoate adverse reaction (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate allergy Preferred (foundation metadata concept)
Zuclopenthixol decanoate allergy (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate in parenteral dosage form Preferred (foundation metadata concept)
Zuclopenthixol decanoate overdose Preferred (foundation metadata concept)
Zuclopenthixol decanoate overdose (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate overdose of undetermined intent Preferred (foundation metadata concept)
Zuclopenthixol decanoate overdose of undetermined intent (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate poisoning Preferred (foundation metadata concept)
Zuclopenthixol decanoate poisoning (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate poisoning of undetermined intent Preferred (foundation metadata concept)
Zuclopenthixol decanoate poisoning of undetermined intent (disorder) Preferred (foundation metadata concept)
Zuclopenthixol decanoate product Preferred (foundation metadata concept)
Zuclopenthixol dihydrochloride Preferred (foundation metadata concept)
Zuclopenthixol dihydrochloride Preferred (foundation metadata concept)
Zuclopenthixol dihydrochloride (product) Preferred (foundation metadata concept)
Zuclopenthixol dihydrochloride (substance) Preferred (foundation metadata concept)
Zuclopenthixol only product Preferred (foundation metadata concept)
Zuclopenthixol only product in oral dose form Preferred (foundation metadata concept)
Zuclopenthixol only product in parenteral dose form Preferred (foundation metadata concept)
Zuclopenthixol overdose Acceptable (foundation metadata concept)
Zuclopenthixol overdose Preferred (foundation metadata concept)
Zuclopenthixol overdose (disorder) Preferred (foundation metadata concept)
Zuclopenthixol overdose of undetermined intent Preferred (foundation metadata concept)
Zuclopenthixol overdose of undetermined intent Acceptable (foundation metadata concept)
Zuclopenthixol overdose of undetermined intent (disorder) Preferred (foundation metadata concept)
Zuclopenthixol poisoning Preferred (foundation metadata concept)
Zuclopenthixol poisoning (disorder) Preferred (foundation metadata concept)
Zuclopenthixol poisoning of undetermined intent Preferred (foundation metadata concept)
Zuclopenthixol poisoning of undetermined intent (disorder) Preferred (foundation metadata concept)
Zuclopenthixol-containing product Preferred (foundation metadata concept)
Zuclopenthixol-containing product in oral dose form Preferred (foundation metadata concept)
Zuclopenthixol-containing product in parenteral dose form Preferred (foundation metadata concept)
Zulu Preferred (foundation metadata concept)
Zulu (ethnic group) Preferred (foundation metadata concept)
Zulu language Preferred (foundation metadata concept)
Zulu language (qualifier value) Preferred (foundation metadata concept)
Zung anxiety status inventory Acceptable (foundation metadata concept)
Zung self rating depression scale score Preferred (foundation metadata concept)
Zung self rating depression scale score (observable entity) Preferred (foundation metadata concept)
Zung self-rating anxiety scale Acceptable (foundation metadata concept)
Zung self-rating depression scale Preferred (foundation metadata concept)
Zung self-rating depression scale (assessment scale) Preferred (foundation metadata concept)
Zung's anxiety status inventory Preferred (foundation metadata concept)
Zung's anxiety status inventory (assessment scale) Preferred (foundation metadata concept)
Zung's self-rating anxiety scale Preferred (foundation metadata concept)
Zung's self-rating anxiety scale (assessment scale) Preferred (foundation metadata concept)
Zuni language Preferred (foundation metadata concept)
Zuni language (qualifier value) Preferred (foundation metadata concept)
Zunian language Preferred (foundation metadata concept)
Zunian language (qualifier value) Preferred (foundation metadata concept)
Zunich Kaye syndrome Acceptable (foundation metadata concept)

Start Previous Page 12989 of 13262 Next End

Reference Sets

Reference set descriptor

Back to Start